4//SEC Filing
Jenusaitis Matthew 4
Accession 0001493152-21-022863
CIK 0001661053other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 9:50 PM ET
Size
7.0 KB
Accession
0001493152-21-022863
Insider Transaction Report
Form 4
Jenusaitis Matthew
Director
Transactions
- Exercise/Conversion
Common Stock
2021-09-13+1,042→ 5,884 total - Exercise/Conversion
Restricted Stock Units
2021-09-13−1,042→ 2,084 total→ Common Stock (1,042 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") converts into one share of common stock of Hancock Jaffe Laboratories, Inc.
- [F2]On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of 1,042 RSUs occurred on September 13, 2021
Documents
Issuer
Hancock Jaffe Laboratories, Inc.
CIK 0001661053
Entity typeother
Related Parties
1- filerCIK 0001357864
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 9:50 PM ET
- Size
- 7.0 KB